Department of Ophthalmology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Xiangya Eye Center, Central South University, Changsha, Hunan, China.
PLoS One. 2019 Apr 1;14(4):e0214684. doi: 10.1371/journal.pone.0214684. eCollection 2019.
This meta-analysis aims to evaluate the incidence of secondary glaucoma in patients under the age of 2 years who underwent congenital cataract surgery with or without primary intraocular lens (IOL) implantation.
An electronic literature search was performed in Medline, EMBASE, and Web of Science databases to retrieve studies between January 2011 and November 2018. Patients with congenital cataract who did primary IOL implantation, aphakia, or secondary IOL implantation followed by receiving extraction surgery were included in this study. Relevant studies meeting defined eligibility criteria were selected and reviewed systematically by meta-analysis. Long-term incidences of secondary glaucoma, which developed at least one year after cataract surgery, were considered and discussed as clinical outcomes in each cohort. The pooled data were analyzed according to a random effects model.
Eight publications involving 892 eyes were included in the current meta-analysis. In the general population of eyes with congenital cataract, the long-term incidence of secondary glaucoma was lower (P = 0.06) in eyes with primary IOL (9.5%) than in eyes without primary IOL (15.1%), including aphakia and secondary IOL. The pooled risk ratio (RR) favors primary IOL implantation in all patients (RR = 0.63). For bilateral congenital cataract, the incidence was 6.7% in eyes with primary IOL implantation, which is significantly lower than the 16.7% in eyes with aphakia and secondary IOL implantation (P<0.05, RR = 0.44). However, for unilateral congenital cataract surgery, the incidence was very similar in eyes with and without primary IOL (12.4% vs 12.0%, P = 0.61, RR = 0.87).
In patients under 2 years of age, primary IOL implantation for bilateral congenital cataract surgery is associated with a lower risk of secondary glaucoma.
本荟萃分析旨在评估 2 岁以下行先天性白内障手术患者中,行或不行原发性人工晶状体(IOL)植入术后继发性青光眼的发生率。
通过电子检索 Medline、EMBASE 和 Web of Science 数据库,检索 2011 年 1 月至 2018 年 11 月期间的研究。纳入行原发性 IOL 植入术、无晶状体或继发性 IOL 植入术后行摘除术的先天性白内障患者。选择符合入选标准的相关研究,采用荟萃分析进行系统评价。将术后至少 1 年发生的继发性青光眼作为临床结局进行分析。采用随机效应模型对汇总数据进行分析。
本荟萃分析共纳入 8 项研究共 892 只眼。在先天性白内障患者人群中,行原发性 IOL 者(9.5%)较不行原发性 IOL 者(15.1%,包括无晶状体和继发性 IOL)发生长期继发性青光眼的风险较低(P = 0.06)。所有患者的汇总风险比(RR)均支持行原发性 IOL 植入术(RR = 0.63)。对于双侧先天性白内障,行原发性 IOL 植入术的眼发生率为 6.7%,显著低于行无晶状体和继发性 IOL 植入术的眼(16.7%,P<0.05,RR = 0.44)。然而,对于单侧先天性白内障手术,行与不行原发性 IOL 的眼发生率非常相似(12.4%比 12.0%,P = 0.61,RR = 0.87)。
对于 2 岁以下患者,双侧先天性白内障手术中行原发性 IOL 植入术与继发性青光眼风险降低相关。